![Ryszard Bublik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ryszard Bublik
Amministratore Delegato presso Social360 Ltd.
Profilo
Ryszard Bublik is the founder and former Chief Executive Officer of Social360 Ltd., a company he founded in 2008.
He is currently a Non-Executive Director at Symbiotec Ltd.
Posizioni attive di Ryszard Bublik
Società | Posizione | Inizio |
---|---|---|
Social360 Ltd.
![]() Social360 Ltd. Miscellaneous Commercial ServicesCommercial Services Social360 Ltd. provides intelligent digital media monitoring and analysis. It offers daily intelligent report, automated influencer alerts, presence and conversation audits, detailed analytics, S360 Political, S360 RAW, and S360 Radar. The company was founded by Ryszard Bublik on September 9, 2009 and is headquartered in London, the United Kingdom. | Amministratore Delegato | 01/01/2008 |
Symbiotec Ltd.
![]() Symbiotec Ltd. BiotechnologyHealth Technology Symbiotec Ltd. is a British company that operates as an active pharmaceutical ingredients (APIs) manufacturing company. The CEO of the company is Paul Gilligan. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Social360 Ltd.
![]() Social360 Ltd. Miscellaneous Commercial ServicesCommercial Services Social360 Ltd. provides intelligent digital media monitoring and analysis. It offers daily intelligent report, automated influencer alerts, presence and conversation audits, detailed analytics, S360 Political, S360 RAW, and S360 Radar. The company was founded by Ryszard Bublik on September 9, 2009 and is headquartered in London, the United Kingdom. | Commercial Services |
Symbiotec Ltd.
![]() Symbiotec Ltd. BiotechnologyHealth Technology Symbiotec Ltd. is a British company that operates as an active pharmaceutical ingredients (APIs) manufacturing company. The CEO of the company is Paul Gilligan. | Health Technology |
- Borsa valori
- Insiders
- Ryszard Bublik